All News
Filter News
Found 808,972 articles
-
Crucell N.V. Announces Start Of Rabies Antibody Product Clinical Trial
12/13/2006
-
Cyclacel Pharmaceuticals, Inc. Submits IND Of CYC116 An Aurora Kinase And VEGRF2 Inhibitor To Treat Cancer
12/13/2006
-
Gemin X Biotechnologies Inc.'s Pan-Bcl-2 Antagonist GX15-070 Permits Rational Combination With Velcade In Mantle Cell Lymphoma
12/13/2006
-
HealthSonix' Research Study Shows Clinically Significant Pain Reduction With Osteoarthritis Patients
12/13/2006
-
Entelos, Inc. Completes New Skin Sensitization Platform With Unilever
12/13/2006
-
Pharmion Corporation New Data Show That The Addition Of Thalidomide To Myeloma Therapies Can Enhance Clinical Activity
12/13/2006
-
Genmab A/S Announces HuMax-ZP3 Cancer Program
12/13/2006
-
Mount Sinai School of Medicine And EXACT Sciences Corporation Announce Publication Of Multi-Center Study Results On Stool DNA Testing For Colon Cancer
12/13/2006
-
New Studies Show Amputations Prevented With Home Use Device Developed By ACI Medical, LLC
12/13/2006
-
Coaxia Inc. Announces FDA Approval Of Clinical Trial For Its Novel Stroke Treatment In Patients up to 24 Hours After Onset
12/13/2006
-
China Sky One Medical, Inc. Purchases Competitor Heilongjiang Tianlong Pharmaceutical Company
12/13/2006
-
Johnson & Johnson Acquisition Of Pfizer Consumer Healthcare Receives Clearance From U.S. Federal Trade Commission (FTC)
12/13/2006
-
Elusys Therapeutics, Inc. And U.S. Army Extend Biodefense Collaboration
12/13/2006
-
Somanta Pharmaceuticals, Inc. Signs Letter Of Intent To Expand Sublicense Agreement With Virium Pharmaceuticals For Phenylbutyrate
12/13/2006
-
Trana Discovery And Southern Research Institute Collaborate To Discover New Classes Of Drugs For The Treatment Of HIV
12/13/2006
-
Affymetrix (Santa Clara, California) And Sysmex Corporation Join Forces To Develop And Market In-Vitro Diagnostic Tests
12/13/2006
-
HollisterStier Contract Manufacturing Enters Agreement With GeneraMedix
12/13/2006
-
ULURU Inc. Release: European Zindaclin Licensing Agreements Restructured; Zindaclin Rights For U.S. Market Licensed; Revenue From Zindaclin Projected At $2.5 Million In 2007
12/13/2006
-
Vion Pharmaceuticals Enters Into Manufacturing Agreement For Cloretazine(R) (VNP40101M) With Ben Venue Laboratories
12/13/2006
-
Dana-Farber Cancer Institute/Harvard Cancer Center Implements Phase Forward's Electronic Data Capture Product For Pediatric Leukemia Study
12/13/2006